Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06989320 · ClinicalTrials.gov registry record · NA
Endogenous Oxalate Synthesis in Idiopathic Calcium Oxalate Kidney Stone Disease
A NA study of Healthy and Healthy Volunteer, sponsored by University of Alabama at Birmingham.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 2
- Study locations
NCT06989320 is a NA study of Healthy and Healthy Volunteer that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 80 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (88% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT06989320, a NA study of Healthy and Healthy Volunteer, is actively recruiting participants, sponsored by University of Alabama at Birmingham.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of this clinical trial study is to test if patients with idiopathic calcium oxalate kidney stones have an increased production of oxalate by the body, which would lead to increased urinary excretion of oxalate. The study will recruit adult patients with a history of calcium oxalate kidney stones and healthy volunteers without kidney stones. Participants will ingest fixed diets containing low amounts of oxalate for 5 days ingest a soluble form of glycolate and vitamin C collect urine, blood, stool during the dietary and oral dosing portions of the study and also collect breath sample during the oral glycolate test
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Low-oxalate diet and glycolate dosing
- DIETARY_SUPPLEMENT Oral glycolate dosing
- DIETARY_SUPPLEMENT Oral 13C- ascorbic acid dosing
Study Locations (2)
Alabama
- United States, Alabama University of Alabama at Birmingham - Birmingham
Texas
- University of Texas South Western Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2025-05-27 |
| Est. Completion | 2031-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06989320
The ClinicalTrials.gov registry entry for NCT06989320 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (88% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 9 conditions, with Healthy appearing as the primary indexed condition, and to 3 interventions - of which Low-oxalate diet and glycolate dosing is the first listed.
NCT06989320 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Alabama, Texas.
Frequently Asked Questions
What is clinical trial NCT06989320 about?
NCT06989320 is a clinical study titled "Endogenous Oxalate Synthesis in Idiopathic Calcium Oxalate Kidney Stone Disease". The goal of this clinical trial study is to test if patients with idiopathic calcium oxalate kidney stones have an increased production of oxalate by the body, which would lead to increased urinary excretion of oxalate. The study will recruit adult patients with a history of calcium oxalate kidney ...
What is the current status of trial NCT06989320?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2025-05-27. Estimated completion is 2031-12-31.
What conditions does trial NCT06989320 study?
This clinical trial studies the following conditions: Healthy, Healthy Volunteer, Nephrolithiasis, Kidney Stones, Urolithiasis.
What interventions are being tested in trial NCT06989320?
The interventions under investigation include: Low-oxalate diet and glycolate dosing (DIETARY_SUPPLEMENT), Oral glycolate dosing (DIETARY_SUPPLEMENT), Oral 13C- ascorbic acid dosing (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06989320?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06989320 being conducted?
This trial has 2 study locations across Alabama, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
-
Oxalate and Citrate in Humans - Response to Citrate
RECRUITING · NA
-
CArdioMEtabolic Function and Reserve Capacity in Healthy Adults: The CAMERA Study
RECRUITING · NA
-
Examining Bronchial Hyperresponsiveness in Primary Ciliary Dyskinesia
RECRUITING · NA
-
Medical Illustration Design Characteristic Evaluation
RECRUITING · NA
-
Sodium vs Potassium Education to Improve Vascular Health
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.